Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 79,259 shares at $13.58 ($1.1M) on 2019-04-01, disclosed to the SEC on 2019-04-02.
Seasonal sale ($1.1M) by President and CEO — this insider has traded CCXI in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |